[{"address1": "North Tower", "address2": "6th Floor 333 Ludlow Street", "city": "Stamford", "state": "CT", "zip": "06902", "country": "United States", "phone": "888 729 1206", "fax": "201 421 2010", "website": "https://www.genedx.com", "industry": "Health Information Services", "sector": "Healthcare", "longBusinessSummary": "GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.", "fullTimeEmployees": 1000, "companyOfficers": [{"maxAge": 1, "name": "Ms. Katherine A. Stueland", "age": 47, "title": "President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 745915, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  Feeley", "age": 42, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 488192, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karen  Ponchner", "title": "Head of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Olivares Ph.D.", "title": "Chief Product & Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jami  Biliboaca", "title": "Head of People Strategy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Kruszka FACMG, M.D., M.P.H.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melanie  Duquette", "title": "Chief Growth Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Sabrina  Dunbar", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Britt  Johnson", "title": "Head of Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1730073600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 84.02, "open": 84.04, "dayLow": 78.21, "dayHigh": 89.1099, "regularMarketPreviousClose": 84.02, "regularMarketOpen": 84.04, "regularMarketDayLow": 78.21, "regularMarketDayHigh": 89.1099, "beta": 2.383, "forwardPE": 277.3333, "volume": 1406065, "regularMarketVolume": 1406065, "averageVolume": 513096, "averageVolume10days": 845520, "averageDailyVolume10Day": 845520, "bid": 83.01, "ask": 83.25, "bidSize": 100, "askSize": 100, "marketCap": 2285620480, "fiftyTwoWeekLow": 1.16, "fiftyTwoWeekHigh": 89.11, "priceToSalesTrailing12Months": 8.553073, "fiftyDayAverage": 45.6964, "twoHundredDayAverage": 24.798225, "currency": "USD", "enterpriseValue": 2254027008, "profitMargins": -0.31246, "floatShares": 17920743, "sharesOutstanding": 27471400, "sharesShort": 2404923, "sharesShortPriorMonth": 2217287, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.08930001, "heldPercentInsiders": 0.25424, "heldPercentInstitutions": 0.62926996, "shortRatio": 4.31, "shortPercentOfFloat": 0.24299999, "bookValue": 7.547, "priceToBook": 11.024248, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -83497000, "trailingEps": -3.09, "forwardEps": 0.3, "enterpriseToRevenue": 8.435, "enterpriseToEbitda": -54.139, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "WGS", "underlyingSymbol": "WGS", "shortName": "GeneDx Holdings Corp.", "longName": "GeneDx Holdings Corp.", "firstTradeDateEpochUtc": 1604500200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "2ffa3076-357b-3ae2-a6e2-462cba4425fb", "gmtOffSetMilliseconds": -14400000, "currentPrice": 83.2, "targetHighPrice": 95.0, "targetLowPrice": 45.0, "targetMeanPrice": 72.5, "targetMedianPrice": 75.0, "recommendationMean": 2.3, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 116460000, "totalCashPerShare": 4.298, "ebitda": -41634000, "totalDebt": 116101000, "quickRatio": 2.003, "currentRatio": 2.405, "totalRevenue": 267228000, "debtToEquity": 56.773, "revenuePerShare": 10.113, "returnOnAssets": -0.08704001, "returnOnEquity": -0.36401, "freeCashflow": -21849876, "operatingCashflow": -55171000, "revenueGrowth": 0.442, "grossMargins": 0.59532, "ebitdaMargins": -0.1558, "operatingMargins": -0.0964, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-31"}]